Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Observational Usage and Efficacy Study of Candesartan in Heart Failure Treatment in France.

Trial Profile

Observational Usage and Efficacy Study of Candesartan in Heart Failure Treatment in France.

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 12 Jun 2013

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Candesartan cilexetil (Primary)
  • Indications Heart failure
  • Focus Therapeutic Use
  • Acronyms SISTOLA
  • Sponsors AstraZeneca

Most Recent Events

  • 12 Jul 2010 Actual end date changed from May 2009 to Jun 2010 as reported by ClinicalTrials.gov.
  • 10 Jun 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
  • 06 Jun 2008 New trial record.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top